导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -5.55% | 232/354 |
| 近一周 | -1.73% | 177/356 |
| 近一月 | -4.40% | 238/362 |
| 近一季 | -3.31% | 237/362 |
| 近半年 | 1.47% | 215/358 |
| 近一年 | -5.55% | 207/349 |
| 近两年 | 15.16% | 237/314 |
| 近三年 | 25.45% | 155/244 |
| 成立以来 | 162.75% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-8.25% 249/360 |
7.13% 154/366 |
- - |
- - |
| 2025 | 6.53% 283/358 |
-11.40% 315/340 |
10.14% 138/348 |
9.77% 154/354 |
-0.55% 184/358 |
| 2024 | 21.84% 86/329 |
2.73% 150/280 |
-0.88% 211/310 |
8.78% 126/318 |
9.99% 3/329 |
| 2023 | 36.15% 45/275 |
14.87% 44/205 |
12.80% 61/230 |
-5.33% 163/262 |
10.99% 76/276 |
| 2022 | -35.20% 148/201 |
-8.87% 70/153 |
-24.60% 153/164 |
3.35% 17/189 |
-8.76% 187/202 |
| 2021 | 25.06% 24/150 |
3.87% 95/312 |
5.77% 126/328 |
0.57% 72/358 |
13.18% 10/151 |
| 2020 | 26.30% 25/103 |
-21.95% 221/280 |
28.71% 46/295 |
14.15% 18/299 |
10.13% 121/305 |
| 2019 | 26.49% 31/88 |
15.55% 49/258 |
4.58% 41/267 |
1.09% 109/253 |
3.55% 163/266 |
| 2018 | -0.58% 16/79 |
- - |
6.99% 23/227 |
6.25% 42/225 |
-15.09% 171/241 |
| 2017 | 19.85% 29/69 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数美元现汇A | 0.4802 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4718 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4729 | 27.33% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 华宝标普美国消费美元 VS. 建信富时100指数(QDII)人民币A(539003) |